Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 2,998 | 837 | 889 | 1,040 | 925 |
| Gross Profit | 2,998 | 837 | 889 | 1,040 | 925 |
| Operating Expenses | 61,164 | 28,673 | 24,770 | 19,586 | 4,056 |
| Operating Income | -58,166 | -27,836 | -23,881 | -18,546 | -3,131 |
| Interest Expense | 11 | 8 | 6 | 6 | 582 |
| Other Income | 1,506 | 525 | 2,014 | 4,026 | -23,065 |
| Pre-tax Income | -56,671 | -27,319 | -21,873 | -14,526 | -26,778 |
| Net Income Continuous | -56,671 | -27,319 | -21,873 | -14,526 | -26,778 |
| Net Income | $-56,671 | $-27,319 | $-21,873 | $-14,526 | $-26,778 |
| EPS Basic Total Ops | -29.75 | -16.50 | -16.00 | -13.25 | -381.50 |
| EPS Basic Continuous Ops | -29.81 | -16.40 | -16.00 | -13.16 | -344.56 |
| EPS Diluted Total Ops | -29.75 | -16.50 | -16.00 | -13.25 | -381.50 |
| EPS Diluted Continuous Ops | -29.81 | -16.40 | -16.00 | -13.16 | -344.56 |
| EPS Diluted Before Non-Recurring Items | -29.75 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-55,806 | $-27,095 | $-23,056 | $-17,995 | $-3,120 |